This review highlights the role of candida albicans in vulvovaginal candidiasis, emphasizing antifungal resistance and the need for alternative therapies.
Key Points
Up to 75% of women experience at least one episode of vulvovaginal candidiasis, indicating a widespread issue.
Virulence factors such as biofilm formation and immune evasion contribute to the persistence of candida albicans.
Resistance to antifungals, particularly with non-albicans species, presents significant treatment challenges.
Preventive measures like maintaining vaginal microbiota balance are crucial for reducing the impact of this fungal infection.